Stock
Reported value
$21.9M
Holders
24
+20 new · −35 exited
Holders’ est. mark
$18.1M
Price effect on 17 books still in the name
Largest holder
$5.58M
Bain Capital Life Sciences Investors, LLC
Notable conviction
Share of each notable manager’s 13F book.
- Renaissance Technologies0.0% · $416.9K
- Fidelity0.0% · $307.5K
- State Street0.0% · $111.9K
Holder count by quarter
Who holds it
Notable only| Investor | Shares | Value | Est. mark | Change |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 664K | $5.58M | $5.16M | Added$864.4K |
| GILEAD SCIENCES, INC. | 650.4K | $5.47M | $5.05M | Cut−$359.5K |
| Frazier Life Sciences Management, L.P. | 422.5K | $3.55M | $3.28M | Cut−$233.6K |
| Sio Capital Management, LLC | 152.5K | $1.28M | $1.18M | Cut−$84.3K |
| VANGUARD CAPITAL MANAGEMENT LLC | 123.7K | $1.04M | — | Held |
| Caligan Partners LP | 112.1K | $943K | — | New |
| Merck & Co., Inc. | 106K | $891.3K | $823.5K | Cut−$58.6K |
| Stonepine Capital Management, LLC | 64.2K | $539.6K | $498.5K | Added$458.8K |
| MORGAN STANLEY | 57.5K | $483.5K | $446.7K | Cut−$54.2K |
| Renaissance Technologies | 49.6K | $416.9K | $385.1K | Added$196.4K |
| AJU IB Investment Co., Ltd. | 47.7K | $401.1K | $370.6K | Cut−$26.4K |
| GEODE CAPITAL MANAGEMENT, LLC | 37.2K | $312.8K | $289K | Added$102.2K |
| Fidelity | 36.6K | $307.5K | $284K | Cut−$20.2K |
| VANGUARD FIDUCIARY TRUST CO | 28.5K | $239.5K | — | Held |
| Velan Capital Investment Management LP | 14.3K | $120.1K | $111K | Added$11.3K |
| Ghisallo Capital Management LLC | 13.8K | $116.1K | $107.2K | Cut−$596.6K |
| State Street | 13.3K | $111.9K | $103.4K | Cut−$7.38K |
| CWM, LLC | 4.21K | $35.4K | — | New |
| UBS Group AG | 4.04K | $34K | $1.58K | Added$33.8K |
| JPMORGAN CHASE & CO | 240 | $1.98K | — | New |
| Vanguard Global Advisers, LLC | 210 | $1.77K | — | Held |
| ROYAL BANK OF CANADA | 91 | $1K | — | New |
| Key Financial Inc | 59 | $496 | $458 | Cut−$35 |
| GSA CAPITAL PARTNERS LLP | 16.9K | $143 | $132 | Added$48 |
Who left
- Bain Capital Life Sciences Investors, LLC$4.72M
- Frazier Life Sciences Management, L.P.$3.79M
- Point72 Asset Management, L.P.$2.56M
- Sio Capital Management, LLC$1.37M
- STEMPOINT CAPITAL LP$1.3M
- Merck & Co., Inc.$949.9K
- Empery Asset Management, LP$757.4K
- Ghisallo Capital Management LLC$712.7K
- MORGAN STANLEY$537.7K
- AJU IB Investment Co., Ltd.$427.5K
- Fidelity$327.7K
- Citadel$279.3K
- Renaissance Technologies$220.5K
- GEODE CAPITAL MANAGEMENT, LLC$210.6K
- State Street$119.3K
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.